LY2109761

Item number	Size	Delivery time	Price
TGM-T2123-2mg	2 mg	7 - 10 business days*	40.00€
TGM-T2123-5mg	5 mg	7 - 10 business days*	63.00€
TGM-T2123-1mL	1 ml	7 - 10 business days*	71.00€
TGM-T2123-10mg	10 mg	7 - 10 business days*	112.00€
TGM-T2123-25mg	25 mg	7 - 10 business days*	198.00€
TGM-T2123-50mg	50 mg	7 - 10 business days*	352.00€
TGM-T2123-100mg	100 mg	7 - 10 business days*	533.00€
TGM-T2123-200mg	200 mg	7 - 10 business days*	768.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: LY2109761 is a novel selective TGF-beta receptor type I/II (TbetaRI/II) dual... more

Close menu

Product information "LY2109761"

Description: LY2109761 is a novel selective TGF-beta receptor type I/II (TbetaRI/II) dual inhibitor with Ki of 38 nM and 300 nM, respectively, shown to negatively affect the phosphorylation of Smad2. Target: Autophagy, TGF-beta/Smad. Smiles: C(CN1CCOCC1)Oc1ccc2c(ccnc2c1)-c1c2CCCn2nc1-c1ccccn1. References: Melisi D, et al. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Mol Cancer Ther. 2008 Apr,7(4):829-40.

Supplier:	TargetMol
Supplier-Nr:	T2123

Properties

MW:	441.52 D
Formula:	C26H27N5O2
Format:	32160405

Database Information

CAS :

700874-71-1| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "LY2109761"

Write a review